Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Industries
Industries
Health
Products 51 to 60 of 63
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
SYN-004 (RIBAXAMASE)
by
Synthetic Biologics
Biotech components:
Microbe
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
12,467,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
SYN
(NYSEMKT)
Value chain stage:
Finished Product
SYN-005
by
Synthetic Biologics
+
Intrexon
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/01 09:27 (7 years ago)
Known funding amount:
24,800,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
SYN
(NYSEMKT)
Value chain stage:
Finished Product
SYNB1020
by
Synlogic
Biotech components:
Microbe
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
+
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
125,800,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
SYBX
(NASDAQ)
Value chain stage:
Finished Product
SYNB1618
by
Synlogic
Biotech components:
Microbe
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/08 14:53 (7 years ago)
Known funding amount:
125,800,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
SYBX
(NASDAQ)
Value chain stage:
Finished Product
Synbio Lantibiotics
by
University of Groningen
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Public Funding
Industry:
Health
Market status:
More information needed
+
Under Development
Organization type(s):
University
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Synthorin™ Protein
by
Synthorx
+
Scripps Research Institute
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
79,000,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
TALEN
by
Cellectis
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
+
France
Country of distribution:
USA
+
France
Intended consumer:
Research
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
17,400,000 EUR
Funding types:
Shareholder Investment
Industry:
Health
+
Multipurpose
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
Web search
Trading symbol:
CLLS, ALCLS
(NASDAQ, EPA)
Value chain stage:
Platform
Engineered Gut Bacteria to Prevent Cholera
by
Cornell University
Biotech components:
Bacteria
Business models:
N/A
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/09/14 10:43 (7 years ago)
Known funding amount:
N/A
Funding types:
Foundation
+
University
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Vitamin D2
by
Nucelis
Biotech components:
Plant
Business models:
B2B
+
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Health
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Personal Care (Ingested)
+
Food
Production process:
Open Release
Source:
N/A
Trading symbol:
N/A
Value chain stage:
Finished Product
Yarrowia Flour
by
Biotech components:
Plant
Business models:
N/A
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Health
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Food
Production process:
Open Release
Source:
N/A
Trading symbol:
N/A
Value chain stage:
Finished Product
1
2
3
4
5
6
7
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
